Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial
Author(s) -
Frederick K. Korley,
Qi Pauls,
Sharon D. Yeatts,
Courtney Marie Cora Jones,
Emily Corbett-Valade,
Robert Silbergleit,
Michael Frankel,
William G. Barsan,
Nathan D. Cahill,
Jeffrey J. Bazarian,
David W. Wright
Publication year - 2020
Publication title -
journal of neurotrauma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.653
H-Index - 149
eISSN - 1557-9042
pISSN - 0897-7151
DOI - 10.1089/neu.2020.7072
Subject(s) - traumatic brain injury , biomarker , glial fibrillary acidic protein , medicine , glasgow outcome scale , endocrinology , placebo , brain damage , pathology , immunohistochemistry , biology , psychiatry , biochemistry , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom